1 (385)
Committee for Risk Assessment (RAC)
Committee for Socio economic Analysis (SEAC)
Background document
to the Opinion on the Annex XV dossier proposing restrictions on Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances
ECHA/RAC/RES O 0000006229 70 02/F ECHA/SEAC/[reference code to be added after the adoption of the SEAC opinion]
EC Number CAS Number
206 397 9 335 67 1
11 September 2015
Annankatu 18, P.O. Box 400, FI 00121 Helsinki, Finland | Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances
About this document
This Background Document to the opinions of RAC and SEAC is an amended version of the Annex XV restriction report submitted by Germany and Norway. The amendments include further information obtained during the public consultation and other relevant information resulting from the opinion making process. The evaluation made by RAC and SEAC of the information presented in this document can be found in their opinions and justification. Where relevant some additional assessment by the RAC or SEAC rapporteurs can be found in boxes in the document.
TABLE OF CONTENTS
Abbreviations ...... 7 About this report ...... 8 A. Proposal ...... 10 A.1 Proposed restriction ...... 10 A.1.1 The identity of the substances ...... 10 A.1.2 Scope and conditions of restriction ...... 12 A.2 Targeting ...... 13 A.3 Summary of the justification ...... 14 A.3.1 Identified hazard and risk ...... 14 A.3.2 Justification that action is required on a community wide basis ...... 16 A.3.3 Justification that the proposed restriction is the most appropriate community wide measure ...... 16 A.3.4 Uncertainties ...... 18 B. Information on hazard and risk ...... 20 B.1 Identity of the substances and physical and chemical properties ...... 20 B.1.1 Name and other identifiers of the substances ...... 20 B.1.2 Physicochemical properties ...... 23 B.1.3 Justification for grouping ...... 27 B.2 Manufacture and uses ...... 28 B.2.1 Production and import of PFOA and PFOA related substances in(to) the EU 28 B.2.2 Uses of PFOA and PFOA related substances ...... 30 B.2.3 Summary and conclusions on manufacturing, import and use of PFOA and related substances ...... 37 B.3 Classification and labelling ...... 38 B.3.1 Classification and labelling in Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation) ...... 38 B.3.2 Classification and labelling in classification and labelling inventory/Industry’s self classification(s) and labelling ...... 38 B.4 Environment ...... 40 B.4.1 Environmental fate properties...... 40 B.4.2 Environmental hazard assessment ...... 61 B.4.3 PBT and vPvB assessment ...... 61 B.4.4 Characterisation of environmental releases and exposure ...... 67 B.4.5 Environmental risk characterisation ...... 89 B.5 Human Health ...... 89 B.5.1 Human health hazard assessment ...... 89 B.5.2 Human health hazard assessment of physico chemical properties ...... 116 B.5.3 Human health exposure assessment ...... 116 B.5.4 Human health risk characterization ...... 130 B.5.5 Summary and discussion on human hazard and risk ...... 137
ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances
C. Available information on alternatives ...... 143 C.1 Identification of potential alternative substances and techniques ...... 143 C.2 Assessment of fluorotelomer based short chain chemistry ...... 145 C.2.1 Availability of fluorotelomer based short chain chemistry ...... 145 C.2.2 Human health risks related to fluorotelomer based short chain chemistry 145 C.2.3 Environment risks related to fluorotelomer based short chain chemistry .. 147 C.2.4 Technical and economic feasibility of fluorotelomer based short chain chemistry ...... 150 C.3 Assessment of alternatives for fluoropolymer polymerisation processing aid ...... 150 C.3.1 CAS 62037 80 3 – Ammonium 2,3,3,3 tetrafluoro 2 (heptafluoropropoxy)propanoate (C3 Dimer salt) ...... 151 C.3.2 EC 480 310 4 – Ammonium 2,2,3 trifluoro 3 (1,1,2,2,3,3 hexafluoro 3 trifluoromethoxypropoxy)propionate (ADONA) ...... 153 C.3.3 CAS 908020 52 0 Ammonium difluoro[1,1,2,2 tetrafluoro 2 (pentafluoroethoxy)ethoxy]acetate (EEA NH4) ...... 156 D. Justification for action on a Community wide basis ...... 159 D.1 Considerations related to human health and environmental risks ...... 159 D.2 Considerations related to internal market ...... 159 D.3 Other considerations ...... 160 D.4 Summary ...... 160 E. Justification why the proposed restriction is the most appropriate Community wide measure ...... 161 E.1 Identification and description of potential risk management options ...... 161 E.1.1 Risk to be addressed the baseline ...... 161 E.1.2 Options for restrictions ...... 163 E.1.3 Other Union wide risk management options than restriction ...... 169 E.2 Assessment of risk management options ...... 173 E.2.1 Restriction option 1a: Phase out of PFOA, its salts, and PFOA related substances over 18 months ...... 173 E.2.2 Restriction option 1b: Phase out of PFOA and PFOA related substances within 18 months including possible exemptions ...... 181 E.3 Comparison of the risk management options ...... 185 E.4 Main assumptions used and decisions made during analysis ...... 185 E.5 The proposed restrictions and summary of the justifications ...... 186 F. Socio economic Assessment of Proposed Restriction ...... 187 F.1 Human health and environmental impacts ...... 187 F.1.1 Risks of PFOA and PFOA related substances as PBT substances ...... 187 F.1.2 Benefits of reducing emissions of PFOA and PFOA related substances ...... 187 F.2 Economic impacts ...... 193 F.2.1 Overview of supply chains affected ...... 193 F.2.2 Cost assessment of the proposed restriction ...... 194 F. 2.3 Use of PFOA and its salts ...... 194 F.2.4 Use of PFOA related substances ...... 197 F.2.5 Summary of economic impacts ...... 200 F.2.6 Cost effectiveness analysis ...... 201 F.3 Social impacts ...... 204 F.4 Wider economic impacts ...... 204 F.5 Distributional impacts ...... 205 F.6 Main assumptions used and decisions made during analysis ...... 205 F.7 Uncertainties ...... 206 G. Stakeholder consultation ...... 207 APPENDIX ...... 208 Appendix B.1 – Examples of PFOA related substances ...... 208 Appendix B.2 Production, import and uses of PFOA, its salts and PFOA related substances ...... 216 Appendix B.4 - Environment ...... 258 Appendix B.5 - Human Health ...... 287 Appendix B.5.1 Acute toxicity ...... 287
2 ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances
Appendix B.5.2 Irritation ...... 287 Appendix B.5.5 Mutagenicity ...... 297 Appendix B.5.6 Carcinogenicity ...... 298 Appendix B.5.7 Additional data on toxicity for reproduction ...... 300 Appendix B.5.8 Other effects ...... 306 Appendix C Alternatives ...... 309 Appendix D Confidential information (removed from the public version of the BD) Appendix E ...... 324 Appendix F ...... 327 Appendix G – Stakeholder consultations ...... 332 G1: Questionnaire to Industry Stakeholder on PFOA, PFOA related Substances and PTFE332 G2: Questionnaire to Call for Evidence ...... 349 References ...... 351
TABLES
Table B.1 1: Substance identity of PFOA ...... 20 Table B.1 2: Examples of PFOA salts (Environment Canada Health Canada, 2012; Nielsen, 2012; OECD, 2007, 2011) ...... 21 Table B.1 3: Selected examples of PFOA related substances (Buck et al., 2011; Environment Canada Health Canada, 2012; Nielsen, 2012; OECD, 2007, 2011; U.S.EPA, 2006)...... 22 Table B.1 4: Overview of physicochemical properties of PFOA ...... 23 Table B.1 5: Overview of physicochemical properties of APFO ...... 25 Table B.1 6: Overview of physicochemical properties of 8:2 FTOH ...... 26 Table B.2 1: Estimated EU demand of PTFE and volumes of PFOA in imported PTFE mixtures ...... 33 Table B.2 2: Summary of the used annual volumes estimated in previous chapters (B.2) .... 37 Table B.3 1: Harmonized classification of PFOA (Index No 607 704 00 2) and APFO (Index No 607 703 00 7) under CLP ...... 38 Table B.3 2: Notified classification and labelling according to CLP criteria for PFOA ...... 39 Table B.3 3: Notified classification and labelling according to CLP criteria for APFO ...... 39 Table B.5 1: Summary of selected animal studies and the estimated LOAEL and/or NOAEL for PFOA ...... 103 Table B.5 2: Assessment factors and calculation of DNEL onfoetal growth ofWT CD 1 mice (Lau et al, 2006) ...... 106 Table B.5 3: Assessment factors and calculation of DNEL on neonatal survival in WT mice (Abbot et al., 2007) ...... 107 Table B.5 4: Assessment factors and calculation of DNEL on delayed mammary gland development (Macon et al., 2011 ...... 109 Table B.5 5: Summary of selected human studies and the estimated LOAEL and/or NOAEL 110 Table B.5 6: Assessment factors and calculation of DNEL on increase in total cholesterol and low density lipid protein (LDL) (Steenland et al., 2009) ...... 112 Table B.5 7: Assessment factors and calculation of DNEL on decrease in foetal birth weight (Fei et al., 2007) ...... 113 Table B.5 8: Overview of the calculated DNELs for workers ...... 114 Table B.5 9: Overview of the calculated DNELs for the general population ...... 115 Table B.5 10: Serum concentrations of PFOA (ng/mL) in occupationally exposed workers (Fromme et al., 2009) and intakes (ng/kg bw/day) back calculated using a one compartment steady state pharmacokinetic model ...... 118 Table B.5 11: Estimated total intakes of PFOA from multiple exposure pathways ...... 123 Table B.5 12: Examples of serum/plasma concentrations of PFOA (ng/mL) in the general European adult population and back calculated intakes using a one compartment steady state pharmacokinetic model ...... 126
3 ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances
Table B.5 13: Examples of serum/plasma concentrations of PFOA (ng/mL) in children world wide ...... 128 Table B.5 14: Examples of serum concentrations of PFOA (ng/mL) in cord blood world wide ...... 129 Table B.5 15: RCR is calculated for fluoropolymer production workers by dividing internal values against the different DNELs...... 132 Table B.5 16: RCR is calculated for professional skiwaxers by dividing internal values against the different DNELs ...... 132 Table B.5 17: RCR is calculated for workers by dividing exposure values against the DNELs for external exposure ...... 134 Table B.5 18: RCR is calculated for internal values measured in the general adult population against the different DNELs obtained ...... 135 Table B.5 19: RCR is calculated for internal values measured in children against the different DNELs obtained. Please note that an RCR for children based on reduced birth weight in offspring was not considered relevant ...... 136 Table C.1 1: Overview of available fluorinated and non fluorinated alternatives for different branches...... 143 Table C.2 1: Human related PBT properties of PFOA and 6:2 FTOH ...... 146 Table C.2 2: Aquatic toxicity data of 6:2 FTOH, 8:2 FTOH and their main metabolites ...... 149 Table C.3 1: Identification and notified classification of three potential PFOA alternatives ... 150 Table C.3 2: Human related PBT properties of PFOA and C3 Dimer salt ...... 151 Table C.3 3: Human related PBT properties of PFOA and ADONA ...... 155 Table C.3 4: Human related PBT properties of PFOA and EEA NH4...... 157 Table E.1 1: Manufacturing and import: Available data on current situation and predicted trend without restriction for PFOA, its salts and PFOA related substances in the EU...... 162 Table E.1 2: Summary of the proposed threshold values for PFOA and PFOA related substances...... 166 Table E.1 3: Assessment of Community wide risk management options other than a restriction under REACH ...... 169 Table F.1 1: Estimated annual use volumes and emissions of PFOA (red) and PFOA related substances (blue) subject to the proposed restriction based on current use (worst case scenario) and post 2015 (more realistic scenario) ...... 189 Table F.2 1: Estimated substitution costs of PFOA in PTFE manufacture (for imported mixtures) ...... 196 Table F.2 2: Estimated annual substitution costs of PFOA related substances in textile treatment based on current use (worst case scenario) and projected for the ‘post 2015’ scenario (more realistic case)...... 199 Table F.2 3: Estimated substitution costs of PFOA related substances in fire fighting foams based on current use (worst case scenario) and projected for post 2015 (more realistic scenario) ...... 199 Table F.2 4: Estimated substitution costs of PFOA related substances in paper treatment based on current use (worst case scenario) and projected for post 2015 (more realistic case) ...... 200 Table F.2 5: Estimated substitution costs of PFOA related substances in coatings and inks based on current use (worst case scenario) and projected for post 2015 (more realistic case) ...... 200 Table F.2 6: Summary of use volumes and, substitution costs estimates of PFOA (red) and PFOA related substances (blue) for current use (worst case scenario) and projected for post 2015 (more realistic case) ...... 201 Table F.2 7: Cost effectiveness estimates for the proposed restriction with regard to different
4 ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances emission sources/uses based on volumes and emissions reduced of PFOA (red) and PFOA related substances (blue) ...... 202 Table F.2 8: Summary of cost effectiveness estimates of total volumes and emissions of PFOA (red) and PFOA related substances (blue) reduced ...... 203 Table F.6 1: Underlying assumptions of estimated volumes of PFOA and PFOA related substances after 2015 (post 2015 scenario) ...... 205 Table A.B.1 1: Examples of PFOA related substances (Buck et al., 2011; Environment Canada Health Canada, 2012; Nielsen, 2012; OECD, 2007, 2011; U.S.EPA, 2006) ...... 208 Table A.B.2 1: Summary of global production volumes of PFOA, PFOA salts and PFOA related substances ...... 218 Table A.B.2 2: Estimated Global Historic APFO Manufacture (status 2006) (OECD, 2006; Prevedouros et al., 2006) ...... 219 Table A.B.2 3: Estimated global historical APFO usage for fluoropolymers production (in tonnes) (excl. PVDF) (OECD, 2006 ...... 219 Table A.B.2 4: Overview of major uses of PFOA and related substances in alphabetical order (modified from synthesis paper (OECD, 2013)) and relevant studies which measured product contents of PFOA and related substances ...... 221 Table A.B.2 5: Residual PFOA in PTFE (Data based on industry consultation (Ökopol, 2014)) ...... 230 Table A.B.2 6: Fluoropolymer production data retrieved from the US EPA stewardship program ...... 231 Table A.B.2 7: List of applications for the use of fluoropolymers (PTFE) and examples (extracted from Annex II, Table 3 (Ökopol, 2014)) ...... 233 Table A.B.2 8: Other uses of PFOA ...... 236 Table A.B.2 9: Outdoor clothing ...... 238 Table A.B.2 10: Workers protection clothing ...... 240 Table A.B.2 11: Membranes for apparel ...... 241 Table A.B.2 12: Treated home textile and upholstery ...... 241 Table A.B.2 13: Treated non woven medical garments ...... 242 Table A.B.2 14: Leather finishing ...... 242 Table A.B.2 15: Carpets ...... 243 Table A.B.2 16: Impregnating sprays/ waterproofing agents ...... 245 Table A.B.2 17: Substances found in new generation AFFF fire fighting foam (Place and Field, 2012) ...... 248 Table A.B.2 18: Fire fighting agents ...... 250 Table A.B.2 19: Substances specified as surface refining and coating agents in the BfR recommendations XXXVI. Paper and board for food contact and recommendation XXXVI/2. Paper and board for baking purposes (German Federal Institut for Risk Assessment, 2013a, b) ...... 251 Table A.B.2 20: Treated paper ...... 252 Table A.B.2 21: Cleaning agents ...... 255 Table A.B.2 22: Floor waxes and stone/wood sealants ...... 256 Table A.B.2 23: Non stick ware ...... 256 Table A.B.2 24: Lubricants ...... 256 Table A.B.2 25: Sealant tapes ...... 257 Table A.B.4 1: Summary degradation PFOA related substances ...... 258 Table A.B.4 2: Overview of emission factors (emission factors used for emission estimates shown in bold) ...... 267 Table A.B.4 3: EPA’s summary Table for 2012 company progress reports (U.S.EPA, 2006) . 270 Table A.B.4 4: US EPA: reported emissions and product content of PFOA and related substances (U.S.EPA, 2006) ...... 271 Table A.B.4 5: US EPA: reported percent reductions in emissions and product content of PFOA
5 ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances and related substances from US facilities (U.S.EPA, 2006) ...... 272 Table A.B.4 6: US EPA: reported emissions and product content of PFOA and related substances from non US facilities (U.S.EPA, 2006) ...... 273 Table A.B.4 7: Emissions from outdoor clothing ...... 274 Table A.B.4 8: Measured levels of PFOA and PFOA related substances from global sampling points in various compartments ...... 275 Table A.B.5 1: Repeated dose toxicity, oral ...... 288 Table A.B.5 2: Repeated dose toxicity, inhalation ...... 295 Table A.B.5 3: Repeated dose toxicity, dermal ...... 296 Table A.B.5 4: Summary of relevant animal studies on carcinogenicity ...... 299 Table A.B.5 5: Summary of relevant studies on fertility ...... 301 Table A.C.1 1: Potential alternatives and technologies ...... 309 Table A.E.2 1: Example of analytical methods for measurement of PFOA in articles and mixtures ...... 325 Table A.E.2 2: Examples for analytical methods to analyse some PFOA related substances in articles and mixtures ...... 326 Table A.F.1 1: Examples of damage events from the use of fire fighting agents/ fertilizers containing PFASs and remediation costs ...... 327
FIGURES
Figure A.1 1: Identity of PFOA ...... 10 Figure A.1 2: Chemical structure of PFOA (top) and PFOA related substances...... 11 Figure B.4 1: Aerobic degradation pathways of 8:2 FTOH in soil and activated sludge ...... 42 Figure B.4 2: Mass balance of PFOA in the Baltic Sea (based on (Filipovic et al., 2013)) ...... 88 Figure C.2 1: Proposed 6:2 FTOH aerobic biodegradation pathways. The single arrows indicate transformation steps based on observed transformation product and the double arrows indicate multiple transformation steps (based on (Zhao et al., 2013a))...... 148 Figure A.B.2 1: Telomerisation process (figure based on (Knepper and Lange, 2012)) ...... 217 Figure A.B.2 2: Share of different manufacturers in the world market of fluoropolymers (Halopolymer.com, 2012) ...... 233
6 ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances
Abbreviations
AFFF Aqueous film forming foam APFO Ammonium perfluoro octanoate AR AFFF Alcohol resistant aqueous film forming foam AR FFFP Alcohol resistant film forming fluoroprotein foams C6 based Fluorochemicals or fluorochemistry related to six fully fluorinated C8 atoms and PFHxA C8 based Fluorochemicals or fluorochemistry related to eight fully fluorinated C8 atoms and PFOA CBI Confidential Business Information diPAP Polyfluoroalkyl phosphoric acid diester ECF Electrochemical fluorination FEP Fluorinated ethylene propylene FFFP Film forming fluoroprotein foam FTAC Fluorotelomer acrylate FTAL Fluorotelomer aldehyde FTCA Fluorotelomer (saturated) carboxylic acid FTI Fluorotelomer iodide FTMAC Fluorotelomer methacrylate FTO Fluorotelomer olefine FTOH Fluorotelomer alcohol FTUCA Fluorotelomer unsaturated carboxylic acid GD gestational day monoPAP Polyfluoroalkyl phosphoric acid monoester Na PFOA Sodium perfluorooctanoate PFA Perfluoroalkoxy alkane PFASs Per and polyfluoroalkyl substances PFCA Perfluorocarboxylic acid PFO Perfluoroctanoate PFOA Perfluorooctanoic acid PFOI Perfluorooctyl iodide PFOS Perfluorooctane sulfonic acid PFPA Perfluoroalkyl phosphonic acid PFPIA Perfluoroalkyl phosphinic acid PFSi Polylfuorinated silanes PND Post natal day POP Persistent organic pollutant PTFE Polytetrafluoroethylene PVDF Polyvinylidene fluoride sFTOH Fluorotelomer secondary alcohol TFE Tetrafluoroethylene
7
ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances
About this report
Perfluorooctanoic acid (PFOA) is one important representative of the substance group of per and polyfluorinated substances (PFASs). The hazard profile of PFOA is well known: PFOA is a persistent, bioaccumulative, and toxic (PBT ) substance, which may cause severe and irreversible adverse effects on the environment and human health. PFOA has a harmonised classification in Annex VI of European Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (CLP) as Carc. 2, Repr. 1B and STOT RE 1 (liver). Due to its PBT and CMR properties, PFOA and its ammonium salt (APFO) have been identified as substances of very high concern (SVHC) under REACH by unanimous agreement between EU Member States in July 2013.
Besides PFOA also other substances in the PFASs group have properties of concern, which are targeted by the following international regulations: Perfluorinated carboxylic acids with a carbon chain of eleven to fourteen carbon atoms are also listed as substances of very high concern on the REACH candidate list because of their very persistent and very bioaccumulative properties. Perfluorooctane sulfonic acid (PFOS) is listed as persistent organic pollutant (POP) in Annex B of the Stockholm Convention.
The former restriction of PFOS under REACH and the current entry in Commission Regulation (EU) No 757/2010 (implementing Annex B of the Stockholm Convention) do not only cover PFOS itself, but also PFOS related substances, which are outlined by the chemical formula: + C8F17 SO 2X (X=OH, metal salt (O M ), halide, amide, and other derivates including polymers). The reason for this is that these PFOS related substances can be degraded to PFOS in the environment.
PFASs consist of carbon chains of different chain length, where the hydrogen atoms are completely (perfluorinated) or partly (polyfluorinated) substituted by fluorine atoms. The very stable bond between carbon and fluorine is only breakable with high energy input. Therefore, perfluorinated acids, like PFOA, are not degradable in the environment. Polyfluorinated substances can be degraded to persistent perfluorinated substances like PFOA under environmental conditions and are therefore precursors. Those PFASs, which can be degraded to PFOA in the environment, are referred to as PFOA related substances in this dossier. PFOA and a number of PFOA related substances are ubiquitously found in humans and the environment even if there are no natural sources known. This includes findings in remote areas like the Arctic, which indicates their potential for long range transport. Due to their outstanding technical properties (to provide water, oil, and grease repellency) man made PFASs are used in various consumer products as well as in industrial applications. These uses lead to the wide dispersive release of PFOA, its salts and related substances into the environment.
To limit the risk of ubiquitous and long term exposure of humans and the environment with PFOA, its salts and PFOA related substances a phase out of these substances is the only effective measure. To achieve this phase out a total ban of manufacture, marketing and use is needed. Especially, the import of articles and mixtures containing PFOA, its salts and PFOA related substances can only be controlled in this way.
In chapter A of this report, the proposed restriction is outlined and a summary of the justification is given. The information on hazard and risk of PFOA, its salts and PFOA related substances is provided in chapter B. Details on the identity of the substances within the scope of this proposal as well as their physical chemical properties are given in chapter B.1. The manufacturing and uses of PFOA, PFOA salts and PFOA related substances are described in
8 ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances chapter B.2, respectively. In chapter B.3 the classification and labelling issues of PFOA are summarized. The structure of chapter B of this proposal has been slightly modified, i.e. the hazard and risk characterization of PFOA, its salts and PFOA related substances for the environment is presented in chapter B.4 and for human health in chapter B.5 . This change of structure was agreed with ECHA and was considered appropriate to take the following aspects into account: in the EU, PFOA was unanimously identified as a PBT substance. Emissions of PBT substances into the environment need to be stopped, the main objective according to Art. 55 is substitution. In addition to the assessment of PFOA and PFOA related substances as PBT substances, a quantitative risk characterization is performed for human health based on the knowledge that PFOA is toxic for reproduction (category 1B) and has been shown to affect cholesterol levels in humans. Overall, emissions to the environment need to be prevented to an extent technically and economically feasible and that will at the same time minimize the risks for human health.
Substitution of PFOA and PFOA related substances is possible as shown in chapter C, where the available alternatives are described. In Chapter D and E it is described that a community wide measure is needed and that a restriction as outlined in chapter A is the most appropriate measure. The socio economic impacts of the proposed restriction are assessed in chapter F. To form an effective restriction proposal reliable data were needed. These were partly obtained in stakeholder consultations, which were performed to address remaining data gaps and are summarised in chapter G.
Only few registration dossiers are so far available for PFOA related substances. No registration is available (yet) for PFOA itself or its salts. Information was obtained from industry surveys performed by OECD, reports from research and studies conducted by different other institutions. Most of these studies and information show the need for risk management. This needs to cover several substances with different uses and emission pathways.
9 ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances
Proposal for a restriction
A. Proposal
A.1 Proposed restriction A.1.1 The identity of the substances
Perfluorooctanoic acid (PFOA, CAS 335 67 1, EC 206 397 9), including its salts and any other substance (covering UVCB and well defined substances including polymers) having linear or branched perfluoroheptyl groups covalently bound to a carbon atom with the formula C 7F15 C as a structural element, including its salts except those derivatives with the formula C 7F15 C X, where X= F, Cl, Br and any other substance having linear or branched perfluorooctyl derivatives with the formula
C8F17 as a structural element, including its salts, except those groups with the formula C 8F17 X, where X= F, Cl, Br or, C8F17 SO 2X (X = OH, Metal salt (O-M + ), halide, amide, and other derivatives including polymers) , C 8F17 C(=O)O X' or C 8F17
CF 2 X' (where X'=any group, including salts) (see Figure A.1 1).
Figure A.1 1: Identity of PFOA
EC number: 206 397 9
EC name: Pentadecafluorooctanoic acid
CAS number: 335 67 1
CAS name: Octanoic acid, pentadecafluoro
IUPAC name: Pentadecafluorooctanoic acid
10 ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances
F F F F F F F O F C C C C C CCC F F F F F F F O H
F F F F F F F F C C C C C CCX F F F F F F F
F F F F F F F F F C C C C C CCC X
F F F F F F F F
Figure A.1 2: Chemical structure of PFOA (top) and PFOA related substances.
Exclusions are necessary for PFNA (C8F17 C(=O)OH ), PFOS (C8F17 SO 2X') and other longer chain PFASs (C8F17 CF 2 X'). These substances are not degraded to PFOA and are therefore no PFOA related substances. The reasons for that are the carboxylic and sulfonic groups. If these groups are connected to a perfluorinated carbon chain, i.e. C 8F16 , an enzymatic reaction to break down the molecule has never been observed (Wang et al., 2005a). An abiotic break down of the molecule has not been observed either.
11 ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances
A.1.2 Scope and conditions of restriction
The original proposal by the Dossier Submitter:
Perfluorooctanoic acid (PFOA, CAS 335 67 1, 1. Shall not be manufactured, used or placed EC 206 397 9), on the market including its salts as substances, and any other substance having linear or as constituents of other substances in branched perfluoroheptyl derivatives with the concentrations equal or above 2 ppb of a formula C 7F15 as a structural element, single substance, including its salts in a mixture in concentrations equal or except those derivatives with the formula above 2 ppb of a single substance
C7F15 X, where X= F, Cl, Br 2. Articles or any parts thereof containing one and any other substance having linear or of the substances in concentrations equal to branched perfluorooctyl derivatives with the or greater than 2 ppb of a single substance formula C 8F17 as a structural element, shall not be placed on the market. including its salts, 3. Paragraph 1 and 2 shall apply from (18 except those derivatives with the formula months after entry into force).
C8F17 X, where X= F, Cl, Br or, C 8F17 SO 2X', 4. By way of derogation, paragraph 2 shall not C8F17 C(=O)OH or C 8F17 CF 2 X' (where X'=any group, including salts) apply to the placing on the market of second hand articles which were in end use in the European Union when the restriction becomes effective.
The modified proposal modified by the Dossier Submitter:
Perfluorooctanoic acid (PFOA, CAS 335 67 1, 1. Shall not be manufactured, used or placed EC 206 397 9), on the market including its salts as substances, and any other substance (covering UVCB and as constituents of other substances in well defined substances including polymers) concentrations equal or above 20 ppb PFOA having linear or branched perfluoroheptyl and 10 000 ppb PFOA related substances of groups covalently bound to a carbon atom the sum of single substances, with the formula C 7F15 C as a structural element, including its salts in a mixture in concentrations equal or above 5 ppb PFOA and 1000 ppb PFOA related except those derivatives with the formula substances of the sum of single substances
C7F15 C X, where X= F, Cl, Br 2. Articles or any parts thereof containing one and any other substance having linear or of the substances in concentrations equal to branched perfluorooctyl groups with the or greater than 2 ppb PFOA and 100 ppb formula C 8F17 as a structural element, PFOA related substances of the sum of single including its salts, substances shall not be placed on the market. except those derivatives with the formula 3. Paragraph 1 and 2 shall apply from (18
12 ANNEX XV PROPOSAL FOR A RESTRICTION – Perfluorooctanoic acid (PFOA), PFOA salts and PFOA related substances
C8F17 X, where X= F, Cl, Br or, C8F17 SO 2X´ (X´= months after entry into force). OH, Metal salt (O-M + ), halide, amide, and 4. By way of derogation, paragraph 2 shall not other derivatives including polymers) , C 8F17 apply to the placing on the market of second C(=O)O X' or C 8F17 CF 2 X' (where X'=any hand articles for which an end use in the group, including salts) European Union before the restriction becomes effective can be demonstrated.
5. By way of derogation, paragraph 2 shall not apply to the placing on the market of recycled material.
6. By way of derogation, paragraph 1 and 2 shall not apply to